“You can make liver. You can make pancreas. You can make bone. Therefore you can make neuro cells. You can make heart cells,” said Dr. Robert Carpenter
Yes, he said make a liver make a heart. From what? Stem cells from your teeth.
“We recently discovered that adult stem cells that don’t have the controversy related to it like embryonic cells have the ability to regenerate and treat a number of illnesses and injuries,” Carpenter said.
Stem cells are being studied to affect other disease like diabetes, kidney problems; liver problems even Parkinson’s disease. It’s in human clinical trials, and
Using two distinct methods, Whitehead Institute researchers have successfully and consistently manipulated targeted genes in both human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells (adult cells that have been reprogrammed to an embryonic stem cell-like state).
In one case, scientists employed proteins known as zinc finger nucleases (ZFNs) to change a single base pair in the genome, allowing them either to insert or remove mutations known to cause early-onset Parkinson’s disease (PD). The second method relies on proteins called transcription activator like effector nucleases (TALENs) capable of altering specific genes with similar efficiency and precision as ZFNs.
The flattening of the world’s economy has spawned a new trend in the local medical-tourism industry: Foreigners are starting to come to the Philippines because of the country’s ever-growing availability of cheap but reliable regenerative or stem-cell treatments.
Dr. Samuel Bernal, consultant on regenerative medicine for the Medical City, said some hospitals in the Philippines are starting to gain vigor in stem-cell treatments. Patients treated last year reached over 100 in number.
“Ours [Philippines] is cheaper compared to other developed and developing nations,” Bernal told the BusinessMirror in a phone interview on Monday after a briefing with the media on “Bioregenerative
Image via Wikipedia
Scientists in Melbourne for the first time have created a human stem cell reserve in Australia using a technique that avoids destroying embryos, which was developed in Japan and the United States.
The team from the Monash medical research institute produced an induced pluripotent stem cell line (IpS) that acts like embryonic stem cells, but are derived from adult skin cells. The method used to reprogram adult stem cells developed last year in Japan and the United States allows for the production of IpSs, which are used to study degenerative diseases like Parkinson’s without having to deal
A new biomaterial that enhances the ability of stem cells to regenerate into nerves and body parts has been developed by Australian and British scientists.
The work was a result of a joint study undertaken by the researchers at the Melbourne-based Monash University and UK-based University of Warwick.
Other biomedical “scaffold” materials, which act as templates for tissue regeneration, already exist but they cannot communicate effectively with the cells they are trying to influence.
The researchers have created a more advanced material that targets specific cells and provides clear signals to these cells to enhance regeneration.